HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Möller Selected Research

Graft vs Host Disease (Graft-Versus-Host Disease)

5/2011In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Möller Research Topics

Disease

17Neoplasms (Cancer)
03/2018 - 01/2000
7B-Cell Lymphoma (Lymphoma, B Cell)
09/2008 - 04/2001
5Hodgkin Disease (Hodgkin's Disease)
02/2018 - 01/2001
5Lymphoma (Lymphomas)
07/2013 - 04/2000
4Carcinoma (Carcinomatosis)
03/2018 - 01/2000
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
03/2003 - 01/2000
2Neoplasm Metastasis (Metastasis)
03/2018 - 08/2007
2Chordoma
03/2018 - 01/2018
2Colorectal Neoplasms (Colorectal Cancer)
11/2013 - 01/2000
2Inflammation (Inflammations)
01/2013 - 09/2001
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2009 - 02/2007
2Colitis
10/2001 - 03/2001
2Pancreatitis
07/2001 - 07/2001
2Necrosis
07/2001 - 07/2001
1Foreign-Body Granuloma (Granuloma, Foreign Body)
12/2019
1Granuloma
12/2019
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
03/2019
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
03/2019
1Chondrosarcoma
03/2018
1Meningioma (Meningiomas)
03/2018
1Sarcoma (Soft Tissue Sarcoma)
03/2018
1Blindness (Hysterical Blindness)
01/2018
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2018
1Squamous Cell Carcinoma of Head and Neck
01/2017
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2015
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2015
1Obesity
01/2013
1Graft vs Host Disease (Graft-Versus-Host Disease)
05/2011
1Adenocarcinoma
10/2008
1Burkitt Lymphoma (Burkitt's Lymphoma)
09/2008
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
02/2007
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2007
1Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome)
10/2006
1Gastritis
06/2006
1Residual Neoplasm
05/2005
1Chromosome Aberrations (Chromosome Abnormalities)
11/2003
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
03/2003
1Poliomyelitis (Polio)
12/2001
1Crohn Disease (Crohn's Disease)
09/2001
1Ulcerative Colitis
09/2001
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
09/2001

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
10/2008 - 03/2001
5Fas Ligand Protein (Fas Ligand)IBA
05/2005 - 01/2000
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2013 - 03/2001
3ParaffinIBA
07/2015 - 01/2006
2VimentinIBA
03/2018 - 01/2018
2S100 Proteins (S 100 Protein)IBA
03/2018 - 01/2018
2Biological ProductsIBA
07/2015 - 09/2008
2AntigensIBA
03/2009 - 04/2000
2Messenger RNA (mRNA)IBA
10/2008 - 07/2001
2Dexamethasone (Maxidex)FDA LinkGeneric
10/2006 - 11/2001
2Immunoglobulin G (IgG)IBA
11/2001 - 05/2001
2DNA (Deoxyribonucleic Acid)IBA
07/2001 - 04/2001
2Taurocholic Acid (Sodium Taurocholate)IBA
07/2001 - 07/2001
2beta 2-Microglobulin (beta 2 Microglobulin)IBA
05/2001 - 03/2001
2DNA ProbesIBA
04/2001 - 03/2000
2PerforinIBA
03/2001 - 04/2000
1Mucin-1 (CA 15-3 Antigen)IBA
03/2018
1Keratins (Keratin)IBA
03/2018
1DenosumabFDA Link
03/2018
1MicroRNAs (MicroRNA)IBA
02/2018
1Small Interfering RNA (siRNA)IBA
01/2018
1Brachyury protein (Brachyury)IBA
01/2018
1Neurofibromin 1 (Neurofibromin)IBA
01/2018
1Imatinib Mesylate (Gleevec)FDA Link
11/2013
1Formaldehyde (Formol)FDA Link
07/2013
1TensinsIBA
09/2012
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
09/2012
1Isoantigens (Alloantigen)IBA
05/2011
1Hyaluronic Acid (Hyaluronan)IBA
03/2009
1alpha-methylacyl-CoA racemaseIBA
02/2008
1OsseusIBA
08/2007
1Diphosphonates (Bisphosphonates)IBA
08/2007
1Phosphotransferases (Kinase)IBA
04/2007
1Tyrosine (L-Tyrosine)FDA Link
04/2007
1Complementary DNA (cDNA)IBA
02/2007
1RNA (Ribonucleic Acid)IBA
02/2007
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2007
1Eosine Yellowish-(YS) (Eosin)IBA
06/2006
1Ribosomal DNA (rDNA)IBA
11/2003
1VaccinesIBA
12/2001
1Immunoglobulins (Immunoglobulin)IBA
11/2001
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
11/2001
1Interleukin-4 (Interleukin 4)IBA
11/2001
1enhanced green fluorescent proteinIBA
10/2001
1Indicators and Reagents (Reagents)IBA
09/2001
1TenascinIBA
09/2001
1Caspase 1 (ICE Protease)IBA
07/2001
1Interleukin-1beta (Interleukin 1 beta)IBA
07/2001
1Enzyme Precursors (Zymogens)IBA
07/2001

Therapy/Procedure

5Therapeutics
03/2018 - 07/2000
3Lasers (Laser)
02/2007 - 01/2006
2Drug Therapy (Chemotherapy)
01/2017 - 01/2001
2Immunotherapy
01/2017 - 03/2009
1Neck Dissection (Radical Neck Dissection)
12/2019
1Breast Implants (Breast Implant)
03/2019
1Induction Chemotherapy
01/2017
1Surgical Instruments (Clip)
03/2012
1Radioimmunotherapy
08/2007
1Restorative Proctocolectomy
09/2001